| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | DUF3398 | 3.01e-05 | 6 | 27 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 3.01e-05 | 6 | 27 | 2 | IPR021816 | |
| Domain | DOCK_C | 1.10e-04 | 11 | 27 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.10e-04 | 11 | 27 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.10e-04 | 11 | 27 | 2 | PS51651 | |
| Domain | DHR_1 | 1.10e-04 | 11 | 27 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.10e-04 | 11 | 27 | 2 | PF14429 | |
| Domain | DHR-2 | 1.10e-04 | 11 | 27 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.10e-04 | 11 | 27 | 2 | PF06920 | |
| Domain | DOCK | 1.10e-04 | 11 | 27 | 2 | IPR026791 | |
| Domain | - | 2.95e-03 | 56 | 27 | 2 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 3.06e-03 | 57 | 27 | 2 | IPR023753 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY | 3.47e-05 | 6 | 22 | 2 | M47788 | |
| Pathway | REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS | 4.86e-05 | 7 | 22 | 2 | MM17070 | |
| Pathway | REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS | 6.47e-05 | 8 | 22 | 2 | M48010 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY | 1.04e-04 | 10 | 22 | 2 | M47789 | |
| Pathway | WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ | 1.52e-04 | 12 | 22 | 2 | M39552 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 1.62e-04 | 69 | 22 | 3 | M16894 | |
| Pathway | BIOCARTA_TID_PATHWAY | 3.91e-04 | 19 | 22 | 2 | M9546 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 3.91e-04 | 19 | 22 | 2 | MM15473 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21139044 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 18483265 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 9819434 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 8856922 | ||
| Pubmed | Roles of the DOCK-D family proteins in a mouse model of neuroinflammation. | 1.87e-06 | 3 | 28 | 2 | 32241915 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 26360782 | ||
| Pubmed | Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. | 3.75e-06 | 4 | 28 | 2 | 8349631 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 10523633 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 19633425 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 19703998 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 15710388 | ||
| Pubmed | JNK-binding protein 1 regulates NF-kappaB activation through TRAF2 and TAK1. | 9.36e-06 | 6 | 28 | 2 | 19385034 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 10097072 | ||
| Pubmed | The RhoGEF DOCK10 is essential for dendritic spine morphogenesis. | 9.36e-06 | 6 | 28 | 2 | 25851601 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 19058874 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 1376319 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 24292678 | ||
| Pubmed | Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis. | 1.74e-05 | 8 | 28 | 2 | 15485920 | |
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 10486249 | ||
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 1679528 | ||
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 11908948 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 4.46e-05 | 499 | 28 | 5 | 22810586 | |
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 7906967 | ||
| Pubmed | 5.65e-05 | 14 | 28 | 2 | 12432077 | ||
| Pubmed | 9.49e-05 | 18 | 28 | 2 | 20602751 | ||
| Pubmed | A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. | 1.06e-04 | 19 | 28 | 2 | 8499946 | |
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 1370487 | ||
| Pubmed | 1.43e-04 | 22 | 28 | 2 | 15103018 | ||
| Pubmed | 1.65e-04 | 347 | 28 | 4 | 17114649 | ||
| Pubmed | 2.13e-04 | 371 | 28 | 4 | 25241761 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 2.17e-04 | 27 | 28 | 2 | 14581517 | |
| Pubmed | Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. | 2.86e-04 | 31 | 28 | 2 | 14684825 | |
| Pubmed | 3.05e-04 | 32 | 28 | 2 | 23750785 | ||
| Pubmed | 3.44e-04 | 170 | 28 | 3 | 15057823 | ||
| Pubmed | Association of gene polymorphisms with chronic kidney disease in Japanese individuals. | 4.55e-04 | 39 | 28 | 2 | 19724895 | |
| Pubmed | 6.06e-04 | 45 | 28 | 2 | 22114352 | ||
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.35e-02 | 206 | 21 | 2 | 682 | |
| GeneFamily | Endogenous ligands | 3.05e-02 | 237 | 21 | 2 | 542 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 | 8.42e-06 | 266 | 28 | 5 | M1286 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.14e-06 | 200 | 28 | 4 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 112 | 28 | 3 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 160 | 28 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 160 | 28 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 170 | 28 | 3 | 7653f1205d4e62abe7e31b1d76f9bbd665e45667 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 173 | 28 | 3 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 176 | 28 | 3 | 24eedbbb406d788630bb16678cceef4492d3999c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 179 | 28 | 3 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-04 | 179 | 28 | 3 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 182 | 28 | 3 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 182 | 28 | 3 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.01e-04 | 183 | 28 | 3 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-04 | 184 | 28 | 3 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 185 | 28 | 3 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 188 | 28 | 3 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 188 | 28 | 3 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-04 | 189 | 28 | 3 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-04 | 190 | 28 | 3 | d0297d678498e346e56cf95fe9e3db7d3ad3b837 | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.25e-04 | 190 | 28 | 3 | b47472dc9fe6ed99c2365203a3d8a59879e74a70 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Macrophage|Liver / Manually curated celltypes from each tissue | 2.28e-04 | 191 | 28 | 3 | bd7fd445e3d6316d0336c109889e7e6dc394a55e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-04 | 192 | 28 | 3 | b9d6cf6068ffa104968f4944cbf8af6faa2b8942 | |
| ToppCell | 21-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 2.35e-04 | 193 | 28 | 3 | 9a8bb44a37f3202e3123a6680bd5545dc91a6d40 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.39e-04 | 194 | 28 | 3 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 194 | 28 | 3 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 195 | 28 | 3 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 2.42e-04 | 195 | 28 | 3 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.46e-04 | 196 | 28 | 3 | 988a3e0688e0a7ba69774497d3b130631bb26c50 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.54e-04 | 198 | 28 | 3 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.54e-04 | 198 | 28 | 3 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.54e-04 | 198 | 28 | 3 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.54e-04 | 198 | 28 | 3 | 02d0d8a212e09c0962ab1dae6a885d26d357f66a | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.57e-04 | 199 | 28 | 3 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | distal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.57e-04 | 199 | 28 | 3 | 547a7c30abc730af2670aee00c7a6af60426c9ac | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 28 | 3 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.61e-04 | 200 | 28 | 3 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.61e-04 | 200 | 28 | 3 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 28 | 3 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 28 | 3 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.61e-04 | 200 | 28 | 3 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc30a3_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.86e-04 | 52 | 28 | 2 | 106dd69be38d8ebd298d825c14ac0eefd8366a1a | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Slc30a3_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.86e-04 | 52 | 28 | 2 | 9eaf9c1276a3e074cf6c476a419546cbbe4d525c | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Cd9_(Mural.Rgs5Acta2.Cd9)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.81e-04 | 74 | 28 | 2 | 7c7e45cf219b0be5cf0d0e5ea5daeb32284c8ccd | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Cd9_(Mural.Rgs5Acta2.Cd9)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.81e-04 | 74 | 28 | 2 | 6183baf43010268f54a6db9332296338f4f74009 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 75 | 28 | 2 | 7f3be37cc378ee115fcb4b0eb9653fc77447aa0a | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat-Inhibitory_Neuron.Gad1Gad2-Chat-Slc17a8.Chat_(cholinergic_interneuron)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.03e-03 | 76 | 28 | 2 | 3073a8ace46ad18bddd22ec8f3a1b59ee2fd989d | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat-Inhibitory_Neuron.Gad1Gad2-Chat-Slc17a8.Chat_(cholinergic_interneuron)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.03e-03 | 76 | 28 | 2 | 3f5865b9cb6648b88eb873018e513c5efb457ae5 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Cacng4_(Non-anterior_nuclei)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.03e-03 | 76 | 28 | 2 | 4afc8d0e79870c635a89dd8e7ca91ebfe482b4ab | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.03e-03 | 76 | 28 | 2 | 041a8984b3ae4bb03ae6db8234c1333ac73098fa | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.15e-03 | 80 | 28 | 2 | 3413ac5e1c1e59eab6a83b889b870a8db4efccb9 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.26e-03 | 84 | 28 | 2 | 9417fffe0ba79f5851920258dcd0f6c09218be13 | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.41e-03 | 89 | 28 | 2 | 42432936a6b4289cc4b42fcb576fb09073f2264b | |
| ToppCell | Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Ccnd1_(Mural.Rgs5Acta2.Ccnd1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.41e-03 | 89 | 28 | 2 | 6c594e13f169970b337c2fc3ab969faf6db1a27a | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.78e-03 | 100 | 28 | 2 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.78e-03 | 100 | 28 | 2 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.78e-03 | 100 | 28 | 2 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.51e-03 | 119 | 28 | 2 | d8fbea9ded96fcc3ebdfb4d28873c563427ce811 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.51e-03 | 119 | 28 | 2 | 9e38f13bf98b9ee44b178300e6f80fd08a006296 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-03 | 121 | 28 | 2 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-5|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.72e-03 | 124 | 28 | 2 | 74f756a50036bd2a825f359529da4fbf691e64f0 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.85e-03 | 127 | 28 | 2 | c4809d8502f460370f824719d69b13b400a2b202 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.94e-03 | 129 | 28 | 2 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Cck_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.94e-03 | 129 | 28 | 2 | 08ecebb7f09d105dfdfd2191fc310910d3baec0f | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 2.98e-03 | 130 | 28 | 2 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-03 | 134 | 28 | 2 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.30e-03 | 137 | 28 | 2 | ed81624b9167255ce88dcf6ad7f1636376ea0525 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.30e-03 | 137 | 28 | 2 | 05ca83c30e3dbe74c81278b3636d57da2c20b458 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.30e-03 | 137 | 28 | 2 | 47859aa25f32367461c1ec75ed9060bee430c6b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-03 | 139 | 28 | 2 | c9bf98bed77415a1438f3f9e441a1346e75c26b0 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 3.45e-03 | 140 | 28 | 2 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-03 | 141 | 28 | 2 | e409da87da5a38ba4d0ccc5e3f8bd89f480f9dab | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-03 | 142 | 28 | 2 | 5690eee2ce1ecd02e34eac4193578bd13c4228b9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.59e-03 | 143 | 28 | 2 | 39060dc1d87505a16e2df95140087c731f099570 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma_Heterologous_Type-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 3.59e-03 | 143 | 28 | 2 | bcf702f976ab91f82a5a4beb0b7c74a372c42ae6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-03 | 143 | 28 | 2 | 8f897278f9ccc82ae35e4f30c5f930b2a3eb509d | |
| ToppCell | COVID-19-Mast_cells-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 3.69e-03 | 145 | 28 | 2 | 5c5fed4620c4c312d1052b8acad910453f7e8fcc | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma-3|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.74e-03 | 146 | 28 | 2 | e55b4acecf4e363b5afa287c747c2e58c4597f3a | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-03 | 147 | 28 | 2 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-03 | 148 | 28 | 2 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.84e-03 | 148 | 28 | 2 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.84e-03 | 148 | 28 | 2 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.89e-03 | 149 | 28 | 2 | 92a8931a51db619fb5f0638d319c02e7838f6559 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-03 | 149 | 28 | 2 | 24a7538b54b2a5291503c7493fefed4e45e8d710 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-03 | 149 | 28 | 2 | cc6224c6b79f43b97adc1ce48ca4906bff2ad318 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-03 | 151 | 28 | 2 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-03 | 151 | 28 | 2 | e243b6c76e59035f10519a86399b598dd2123f87 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-03 | 151 | 28 | 2 | cdd2ce0969da446616627e3569bbe5a5d9b475bd | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.99e-03 | 151 | 28 | 2 | 0f8f07e44c6edaf09574930b416fdce14d67095a | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-03 | 152 | 28 | 2 | f717aae4882e9b67e5e40f4ef5b0d35f74a89165 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-03 | 152 | 28 | 2 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-03 | 152 | 28 | 2 | 88a810d41edb5a917c23cb5ba5a387227e1312cb | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-03 | 154 | 28 | 2 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-03 | 154 | 28 | 2 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-03 | 154 | 28 | 2 | 87de3be89e92d2e3980eaf973ee729ad871342aa | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 4.15e-03 | 154 | 28 | 2 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | PBMC-Mild-cDC_6|Mild / Compartment, Disease Groups and Clusters | 4.26e-03 | 156 | 28 | 2 | 3db686849844120b3e376599929d11ad06f0d577 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.26e-03 | 156 | 28 | 2 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-03 | 157 | 28 | 2 | b6ecf1d8c6a465ff31cbc181e00ea88b76b38e19 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-03 | 157 | 28 | 2 | 01ad5cbaf91010e79216e1fb37b7b890618c5f28 | |
| Disease | Mechanical Allodynia | 5.52e-05 | 84 | 26 | 3 | C2936719 | |
| Disease | Allodynia | 5.52e-05 | 84 | 26 | 3 | C0458247 | |
| Disease | Hyperalgesia, Secondary | 5.52e-05 | 84 | 26 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 5.52e-05 | 84 | 26 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 5.52e-05 | 84 | 26 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 5.52e-05 | 84 | 26 | 3 | C0751213 | |
| Disease | Hyperalgesia | 5.52e-05 | 84 | 26 | 3 | C0020429 | |
| Disease | BMI-adjusted leptin measurement | 7.78e-05 | 15 | 26 | 2 | EFO_0007793 | |
| Disease | protein C measurement | 1.01e-04 | 17 | 26 | 2 | EFO_0004633 | |
| Disease | prothrombin time measurement | 1.55e-04 | 21 | 26 | 2 | EFO_0008390 | |
| Disease | insulin sensitivity measurement | 1.87e-04 | 23 | 26 | 2 | EFO_0004471 | |
| Disease | partial thromboplastin time | 2.04e-04 | 24 | 26 | 2 | EFO_0004310 | |
| Disease | glycerol measurement | 2.40e-04 | 26 | 26 | 2 | EFO_0010115 | |
| Disease | Ischemic stroke, factor VII measurement | 2.99e-04 | 29 | 26 | 2 | EFO_0004619, HP_0002140 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 4.87e-04 | 766 | 26 | 5 | EFO_0004713, GO_0097366 | |
| Disease | venous thromboembolism, factor VII measurement | 5.15e-04 | 38 | 26 | 2 | EFO_0004286, EFO_0004619 | |
| Disease | Hypotension | 1.00e-03 | 53 | 26 | 2 | C0020649 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.08e-03 | 914 | 26 | 5 | EFO_0004532 | |
| Disease | fatty acid measurement, linoleic acid measurement | 1.64e-03 | 68 | 26 | 2 | EFO_0005110, EFO_0006807 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGYGIQKGNKHWIIK | 281 | P43235 | |
| KKQGYSTGLIGKWHQ | 126 | P54793 | |
| KKSWEVYQGVCQKGG | 341 | P30411 | |
| IWGKSGHIQTALYGK | 71 | P08910 | |
| LGQYKLNWKHCKGIS | 196 | Q8TCP9 | |
| GVLGGYIQKKKELWG | 86 | P06400 | |
| GTVYKGKWHGDVAVK | 361 | P04049 | |
| GGWNEGEKKYKKCIQ | 571 | Q9H511 | |
| KKGHVYLVGWQTLGI | 326 | Q14397 | |
| KKNWIQYKEGFGHLS | 231 | P02679 | |
| HWQKKVINKGLFFLG | 416 | O15229 | |
| SQKGGVIKQGWLHKA | 161 | Q5JSL3 | |
| QKGGITKHGWLYKGN | 171 | Q9BZ29 | |
| LTGQKKGWKLRYHGD | 276 | P09871 | |
| YVHYWEKGGIQQVKG | 176 | P38484 | |
| EIYHLGWKKLKQGVT | 221 | Q9Y6H8 | |
| GEYLKKEIGQHVAGW | 156 | Q6QHF9 | |
| GAVNKYVIGWKKSEG | 1391 | Q9P2F8 | |
| TGVHKYKWLKQNVQG | 341 | Q9BVR0 | |
| GGLKIYVWKGKKANE | 291 | P09327 | |
| GIYIWKIGNFGMHLK | 351 | Q9Y4K3 | |
| YKQGQHWLEKKDVVG | 126 | P67812 | |
| IHTGGKPYKCNVWKV | 811 | Q96SE7 | |
| GKFIQWNIHKSGLKV | 626 | A4D1P6 | |
| EGQGHWLVVQKGNLK | 31 | Q6P2D8 | |
| HGIGLESKGKWVYKG | 71 | Q8WXH2 | |
| GIYGHLFLWIVKKIN | 401 | Q6PIF6 | |
| VTNGKHGKKINGTWN | 481 | Q13224 |